CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 82.12% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money
1.4972
5.07%
  • Summary
  • Historical Data
Trading сonditions
Spread 0.0256
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.023346 %
Charges from full value of position ($-4.44)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.023346%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.001124 %
Charges from full value of position ($0.21)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.001124%
Overnight fee time 22:00 (UTC)
Min traded quantity 0.01
Currency USD
Margin 5.00%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 1.5772
Open 1.5972
1-Year Change 24.4%
Day's Range 1.4672 - 1.6072
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Jan 17, 2025 1.4972 -0.1500 -9.11% 1.6472 1.6472 1.4472
Jan 16, 2025 1.5772 0.0700 4.64% 1.5072 1.6972 1.5072
Jan 15, 2025 1.5172 -0.1500 -9.00% 1.6672 1.6672 1.4972
Jan 14, 2025 1.5672 -0.3100 -16.51% 1.8772 1.8772 1.5272
Jan 13, 2025 1.8672 0.1400 8.11% 1.7272 2.0172 1.5472
Jan 10, 2025 1.9072 0.0100 0.53% 1.8972 2.4272 1.8672
Jan 8, 2025 1.8772 0.1700 9.96% 1.7072 2.7672 1.1672
Jan 7, 2025 2.2172 0.5800 35.43% 1.6372 3.7772 1.4372
Jan 6, 2025 0.7972 0.0099 1.26% 0.7873 0.8073 0.7672
Jan 3, 2025 0.7672 -0.0001 -0.01% 0.7673 0.8073 0.7672
Jan 2, 2025 0.7673 0.0380 5.21% 0.7293 0.7773 0.7293
Dec 31, 2024 0.7437 0.0054 0.73% 0.7383 0.7721 0.7244
Dec 30, 2024 0.7372 -0.0200 -2.64% 0.7572 0.7580 0.7072
Dec 27, 2024 0.7692 0.0120 1.58% 0.7572 0.7773 0.7472
Dec 26, 2024 0.7573 -0.0400 -5.02% 0.7973 0.8092 0.6982
Dec 24, 2024 0.7822 0.0050 0.64% 0.7772 0.7847 0.7672
Dec 23, 2024 0.8023 -0.0149 -1.82% 0.8172 0.8172 0.7972
Dec 20, 2024 0.7997 0.0474 6.30% 0.7523 0.7997 0.7272
Dec 19, 2024 0.7592 -0.0280 -3.56% 0.7872 0.7872 0.7492
Dec 18, 2024 0.7873 -0.0049 -0.62% 0.7922 0.8112 0.7872

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 3:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Hoth Therapeutics Company profile

About Hoth Therapeutics Inc

Hoth Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing a therapy for dermatological disorders including atopic dermatitis (eczema), chronic wounds, psoriasis, asthma and acne. The Company is also focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer, a treatment for asthma and allergies using inhalational administration, a topical treatment for patients with lupus, a treatment for mast-cell derived cancers and anaphylaxis, and a treatment for lung diseases resulting from bacterial infections. The Company's product pipelines include HT-001, HT-003, HT-004 and others. HT-001 is used to treat patients with rash and skin disorders associated with initial and repeat courses of tyrosine kinase epidermal growth factor receptor (EGFR) inhibitor therapy. It is also developing a COVID-19 treatment as well as a diagnostic device for the detection of viruses via a mobile device.

Financial summary

BRIEF: For the nine months ended 30 September 2021, Hoth Therapeutics Inc revenues was not reported. Net loss increased 68% to $10.8M. Higher net loss reflects Research and development increase from $2.1M to $5.4M (expense), Compensation and related expenses (inclu increase from $1.2M to $2.5M (expense), Other general and administrative expense increase of 68% to $606K (expense).

Industry: Pharmaceuticals (NEC)

1 Rockefeller Plz Ste 1039
10020-2003

People also watch

BTC/USD

104,252.25 Price
+4.290% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 50.00

US100

21,441.70 Price
+1.820% 1D Chg, %
Long position overnight fee -0.0233%
Short position overnight fee 0.0011%
Overnight fee time 22:00 (UTC)
Spread 7.0

ETH/USD

3,435.27 Price
+3.830% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 1.75

Gold

2,703.08 Price
-0.430% 1D Chg, %
Long position overnight fee 0.0056%
Short position overnight fee -0.0138%
Overnight fee time 22:00 (UTC)
Spread 0.60

Still looking for a broker you can trust?

Join the 660,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading